Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ionis Pharmaceuticals Total Liabilities and Share Holders Equity 2010-2024 | IONS

Ionis Pharmaceuticals total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Ionis Pharmaceuticals total liabilities and share holders equity for the quarter ending December 31, 2024 was $3.004B, a 0.45% increase year-over-year.
  • Ionis Pharmaceuticals total liabilities and share holders equity for 2024 was $3.004B, a 0.45% increase from 2023.
  • Ionis Pharmaceuticals total liabilities and share holders equity for 2023 was $2.99B, a 18% increase from 2022.
  • Ionis Pharmaceuticals total liabilities and share holders equity for 2022 was $2.534B, a 2.98% decline from 2021.
  
Ionis Pharmaceuticals Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $3,004
2023 $2,990
2022 $2,534
2021 $2,612
2020 $2,390
2019 $3,233
2018 $2,668
2017 $1,323
2016 $912
2015 $948
2014 $956
2013 $847
2012 $546
2011 $485
2010 $550
2009 $657
Ionis Pharmaceuticals Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-12-31 $3,004
2024-09-30 $3,081
2024-06-30 $2,691
2024-03-31 $2,764
2023-12-31 $2,990
2023-09-30 $2,934
2023-06-30 $2,971
2023-03-31 $2,885
2022-12-31 $2,534
2022-09-30 $2,422
2022-06-30 $2,456
2022-03-31 $2,519
2021-12-31 $2,612
2021-09-30 $2,415
2021-06-30 $2,497
2021-03-31 $2,249
2020-12-31 $2,390
2020-09-30 $3,096
2020-06-30 $3,079
2020-03-31 $3,091
2019-12-31 $3,233
2019-09-30 $2,895
2019-06-30 $2,878
2019-03-31 $2,836
2018-12-31 $2,668
2018-09-30 $2,248
2018-06-30 $2,247
2018-03-31 $1,300
2017-12-31 $1,323
2017-09-30 $1,253
2017-06-30 $1,091
2017-03-31 $1,084
2016-12-31 $912
2016-09-30 $844
2016-06-30 $811
2016-03-31 $876
2015-12-31 $948
2015-09-30 $988
2015-06-30 $976
2015-03-31 $955
2014-12-31 $956
2014-09-30 $794
2014-06-30 $818
2014-03-31 $835
2013-12-31 $847
2013-09-30 $882
2013-06-30 $789
2013-03-31 $553
2012-12-31 $546
2012-09-30 $486
2012-06-30 $472
2012-03-31 $471
2011-12-31 $485
2011-09-30 $506
2011-06-30 $530
2011-03-31 $506
2010-12-31 $550
2010-09-30 $576
2010-06-30 $606
2010-03-31 $600
2009-12-31 $657
2009-09-30 $681
2009-06-30 $709
2009-03-31 $725
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.212B $0.705B
Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $94.222B 35.35
Zoetis (ZTS) United States $71.986B 26.86
Daiichi Sankyo, - (DSNKY) Japan $47.632B 24.23
Takeda Pharmaceutical (TAK) Japan $45.406B 9.03
Sandoz Group AG (SDZNY) Switzerland $19.756B 0.00
Summit Therapeutics (SMMT) United States $18.307B 0.00
Merck (MKKGY) Germany $17.693B 14.64
United Therapeutics (UTHR) United States $13.893B 12.29
Shionogi (SGIOY) Japan $13.832B 13.86
Neurocrine Biosciences (NBIX) United States $11.630B 39.84
IPSEN (IPSEY) France $9.997B 0.00
Orion OYJ (ORINY) Finland $8.541B 23.10
Corcept Therapeutics (CORT) United States $7.569B 61.53
Stevanato Group S.p.A (STVN) Italy $6.808B 41.63
Madrigal Pharmaceuticals (MDGL) United States $6.651B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.019B 0.00
Soleno Therapeutics (SLNO) United States $3.843B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.062B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.776B 9.73
Hypermarcas (HYPMY) Brazil $2.407B 15.83
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.312B 12.64
NewAmsterdam Pharma (NAMS) Netherlands $2.116B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.076B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.765B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.650B 0.00
Guardian Pharmacy Services (GRDN) United States $1.613B 0.00
Indivior (INDV) United States $1.514B 6.42
Evotec AG (EVO) Germany $1.388B 0.00
ARS Pharmaceuticals (SPRY) United States $1.325B 168.62
Dyne Therapeutics (DYN) United States $1.283B 0.00
Ocular Therapeutix (OCUL) United States $1.187B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.108B 45.06
Enliven Therapeutics (ELVN) United States $0.914B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.907B 0.00
Collegium Pharmaceutical (COLL) United States $0.876B 4.73
Ardelyx (ARDX) United States $0.871B 0.00
Harrow (HROW) United States $0.865B 0.00
Xeris Biopharma Holdings (XERS) United States $0.807B 0.00
Cronos Group (CRON) Canada $0.771B 0.00
Akebia Therapeutics (AKBA) United States $0.686B 0.00
AleAnna (ANNA) United States $0.679B 0.00
Organogenesis (ORGO) United States $0.677B 0.00
Xencor (XNCR) United States $0.625B 0.00
KalVista Pharmaceuticals (KALV) United States $0.606B 0.00
Bioventus (BVS) United States $0.557B 14.17
Savara (SVRA) United States $0.556B 0.00
USANA Health Sciences (USNA) United States $0.543B 11.81
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Relay Therapeutics (RLAY) United States $0.514B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.495B 0.00
Elite Pharmaceuticals (ELTP) United States $0.466B 0.00
Altimmune (ALT) United States $0.447B 0.00
Zevra Therapeutics (ZVRA) United States $0.426B 0.00
CytoDyn (CYDY) United States $0.417B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.408B 0.00
Tourmaline Bio (TRML) United States $0.404B 0.00
Verve Therapeutics (VERV) United States $0.399B 0.00
Siga Technologies (SIGA) United States $0.389B 8.12
Oruka Therapeutics (ORKA) United States $0.365B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.13
Heron Therapeutics (HRTX) United States $0.331B 0.00
Aquestive Therapeutics (AQST) United States $0.274B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.27
Avita Medical (RCEL) United States $0.247B 0.00
Wellgistics Health (WGRX) United States $0.216B 0.00
ProKidney (PROK) United States $0.205B 0.00
OmniAb (OABI) United States $0.192B 0.00
MediWound (MDWD) Israel $0.189B 0.00
Esperion Therapeutics (ESPR) United States $0.177B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Nanobiotix S.A (NBTX) France $0.158B 0.00
Inhibikase Therapeutics (IKT) United States $0.156B 0.00
4D Molecular Therapeutics (FDMT) United States $0.150B 0.00
Profound Medical (PROF) Canada $0.150B 0.00
Korro Bio (KRRO) United States $0.145B 0.00
Larimar Therapeutics (LRMR) United States $0.143B 0.00
Aclaris Therapeutics (ACRS) United States $0.142B 0.00
Protara Therapeutics (TARA) United States $0.130B 0.00
Aldeyra Therapeutics (ALDX) United States $0.129B 0.00
Lyell Immunopharma (LYEL) United States $0.126B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Nektar Therapeutics (NKTR) United States $0.115B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.113B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.113B 0.00
Lexeo Therapeutics (LXEO) United States $0.100B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Galectin Therapeutics (GALT) United States $0.088B 0.00
Achieve Life Sciences (ACHV) Canada $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Cassava Sciences (SAVA) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.082B 13.45
Corbus Pharmaceuticals Holdings (CRBP) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.081B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.075B 0.00
Inotiv (NOTV) United States $0.075B 0.00
Context Therapeutics (CNTX) United States $0.069B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.063B 50.00
Assertio Holdings (ASRT) United States $0.061B 0.00
Vivani Medical (VANI) United States $0.060B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Karyopharm Therapeutics (KPTI) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Prelude Therapeutics (PRLD) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.033B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Surrozen (SRZN) United States $0.029B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
BioVie (BIVI) United States $0.023B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 7.52
Lipocine (LPCN) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.47
Plus Therapeutics (PSTV) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00